![Frontiers | Symptom diaries as a digital tool to detect SARS-CoV-2 infections and differentiate between prevalent variants Frontiers | Symptom diaries as a digital tool to detect SARS-CoV-2 infections and differentiate between prevalent variants](https://www.frontiersin.org/files/Articles/1030939/fpubh-10-1030939-HTML/image_m/fpubh-10-1030939-t001.jpg)
Frontiers | Symptom diaries as a digital tool to detect SARS-CoV-2 infections and differentiate between prevalent variants
![Vaccines | Free Full-Text | SARS-CoV-2 Symptoms during the Omicron Surge Differ between Boosted and Vaccinated Non-Boosted Persons Vaccines | Free Full-Text | SARS-CoV-2 Symptoms during the Omicron Surge Differ between Boosted and Vaccinated Non-Boosted Persons](https://www.mdpi.com/vaccines/vaccines-12-00327/article_deploy/html/images/vaccines-12-00327-g002.png)
Vaccines | Free Full-Text | SARS-CoV-2 Symptoms during the Omicron Surge Differ between Boosted and Vaccinated Non-Boosted Persons
![PDF) COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history PDF) COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history](https://www.researchgate.net/publication/379151931/figure/fig1/AS:11431281230791642@1711119567700/CONSORT-diagram-https-doiorg-101371-journalpone0294897g001_Q320.jpg)
PDF) COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
![Vaccines | Free Full-Text | SARS-CoV-2 Symptoms during the Omicron Surge Differ between Boosted and Vaccinated Non-Boosted Persons Vaccines | Free Full-Text | SARS-CoV-2 Symptoms during the Omicron Surge Differ between Boosted and Vaccinated Non-Boosted Persons](https://www.mdpi.com/vaccines/vaccines-12-00327/article_deploy/html/images/vaccines-12-00327-g001-550.jpg)
Vaccines | Free Full-Text | SARS-CoV-2 Symptoms during the Omicron Surge Differ between Boosted and Vaccinated Non-Boosted Persons
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history | PLOS ONE
![Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-34244-2/MediaObjects/41467_2022_34244_Fig1_HTML.png)
Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications
![Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection | Scientific Reports Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-11103-0/MediaObjects/41598_2022_11103_Fig1_HTML.png)
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection | Scientific Reports
![Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection | Scientific Reports Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-11103-0/MediaObjects/41598_2022_11103_Fig2_HTML.png)
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection | Scientific Reports
![PDF) Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD) PDF) Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD)](https://i1.rgstatic.net/publication/367653168_Qualitative_interviews_to_evaluate_content_validity_of_the_ACTIV-2_COVID-19_Symptom_Diary_ACSD/links/63da5bf9c465a873a2768333/largepreview.png)
PDF) Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD)
![Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults | Nature Medicine Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01780-9/MediaObjects/41591_2022_1780_Fig4_HTML.png)
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults | Nature Medicine
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history | PLOS ONE
![Frontiers | Symptom diaries as a digital tool to detect SARS-CoV-2 infections and differentiate between prevalent variants Frontiers | Symptom diaries as a digital tool to detect SARS-CoV-2 infections and differentiate between prevalent variants](https://www.frontiersin.org/files/Articles/1030939/fpubh-10-1030939-HTML/image_m/fpubh-10-1030939-g001.jpg)